Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome.

Hanevik K, Kristoffersen EK, Sørnes S, Mørch K, Næss H, Rivenes AC, Bødtker JE, Hausken T, Langeland N.

BMC Infect Dis. 2012 Oct 14;12:258. doi: 10.1186/1471-2334-12-258.

2.

Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome.

Hanevik K, Kristoffersen E, Mørch K, Rye KP, Sørnes S, Svärd S, Bruserud Ø, Langeland N.

BMC Immunol. 2017 Jan 28;18(1):5. doi: 10.1186/s12865-017-0190-3.

3.

Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course.

Mørch K, Hanevik K, Rivenes AC, Bødtker JE, Næss H, Stubhaug B, Wensaas KA, Rortveit G, Eide GE, Hausken T, Langeland N.

BMC Gastroenterol. 2013 Feb 12;13:28. doi: 10.1186/1471-230X-13-28.

4.

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.

J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68.

5.

Study of immune alterations in patients with chronic fatigue syndrome with different etiologies.

Racciatti D, Dalessandro M, Delle Donne L, Falasca K, Zingariello P, Paganelli R, Pizzigallo E, Vecchiet J.

Int J Immunopathol Pharmacol. 2004 May-Aug;17(2 Suppl):57-62.

PMID:
15345193
6.

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.

BMC Immunol. 2015 Jun 2;16:35. doi: 10.1186/s12865-015-0101-4.

7.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
8.

Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence.

Naess H, Nyland M, Hausken T, Follestad I, Nyland HI.

BMC Gastroenterol. 2012 Feb 8;12:13. doi: 10.1186/1471-230X-12-13.

9.

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, Broderick G, Klimas NG.

PLoS One. 2010 May 25;5(5):e10817. doi: 10.1371/journal.pone.0010817.

10.

Development of functional gastrointestinal disorders after Giardia lamblia infection.

Hanevik K, Dizdar V, Langeland N, Hausken T.

BMC Gastroenterol. 2009 Apr 21;9:27. doi: 10.1186/1471-230X-9-27.

12.

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.

J Transl Med. 2012 May 9;10:88. doi: 10.1186/1479-5876-10-88.

13.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.

J Transl Med. 2011 May 28;9:81. doi: 10.1186/1479-5876-9-81.

14.

Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study.

Hanevik K, Wensaas KA, Rortveit G, Eide GE, Mørch K, Langeland N.

Clin Infect Dis. 2014 Nov 15;59(10):1394-400. doi: 10.1093/cid/ciu629. Epub 2014 Aug 12.

15.

Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Brenu EW, Ashton KJ, van Driel M, Staines DR, Peterson D, Atkinson GM, Marshall-Gradisnik SM.

J Affect Disord. 2012 Dec 10;141(2-3):261-9. doi: 10.1016/j.jad.2012.03.037. Epub 2012 May 8.

PMID:
22572093
16.

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.

J Transl Med. 2015 Sep 14;13:299. doi: 10.1186/s12967-015-0653-3.

17.

Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.

Peakman M, Deale A, Field R, Mahalingam M, Wessely S.

Clin Immunol Immunopathol. 1997 Jan;82(1):83-91.

PMID:
9000046
18.

Chronic fatigue syndrome following a toxic exposure.

Racciatti D, Vecchiet J, Ceccomancini A, Ricci F, Pizzigallo E.

Sci Total Environ. 2001 Apr 10;270(1-3):27-31.

PMID:
11327394
19.

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, Huth TK, Hardcastle SL, Fuller K, Kaur M, Johnston S, Ramos SB, Staines DR, Marshall-Gradisnik SM.

Int Immunol. 2014 Apr;26(4):233-42. doi: 10.1093/intimm/dxt068. Epub 2013 Dec 16.

PMID:
24343819
20.

Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.

Ramos S, Brenu E, Broadley S, Kwiatek R, Ng J, Nguyen T, Freeman S, Staines D, Marshall-Gradisnik S.

Asian Pac J Allergy Immunol. 2016 Dec;34(4):300-305. doi: 10.12932/AP0733.

Supplemental Content

Support Center